Michael K Williams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 |
Richard M Glover Ii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Medical Center Dr, Ste 210, Newton, KS 67114 Phone: 316-283-2800 Fax: 316-283-3575 |
Timothy B Wiens, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 |
Leslie M Luinstra, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-284-5155 Fax: 316-284-5110 |
Angel Teck, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 131-628-3610 Fax: 316-284-5050 |
Jana Nisly, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 |
Troy Allen Holdeman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Medical Center Dr, Suite 210, Newton, KS 67114 Phone: 316-283-2800 |
Chad Sharp, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 N Main St, Suite 300, Newton, KS 67114 Phone: 316-282-9614 Fax: 316-284-9602 |
Ashley Nicole Weis, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-284-5155 Fax: 316-284-5050 |
Joseph W Luinstra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 |
Jennifer S Koontz, M.D. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Medical Center Dr, Newton, KS 67114 Phone: 316-283-9977 Fax: 316-283-0966 |
Robyn D Hartvickson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Medical Center Drive, Suite 210, Newton, KS 67114 Phone: 316-283-2800 Fax: 316-283-3575 |
Dr. David L Bohlender, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 301 N Main St, Suite 300, Newton, KS 67114 Phone: 316-282-9614 Fax: 316-284-9602 |
Dr. Mario A Lanza, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 907-258-1257 |
Gerald R Lindholm, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 Medical Center Drive, Suite 210, Newton, KS 67114 Phone: 316-283-2800 Fax: 316-283-3575 |
Randall V Goering, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-283-6103 Fax: 316-283-1333 |
Stacy B Slechta, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Medical Center Drive, Suite 210, Newton, KS 67114 Phone: 316-283-2800 Fax: 316-283-3575 |
Dr. Daniel V Lygrisse, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 301 N Main St, Ste. 300, Newton, KS 67114 Phone: 316-282-9614 |
News Archive
Heroin use is associated with excessive histone acetylation, an epigenetic process that regulates gene expression, and more years of drug use correlate with higher levels of hyperacetylation, according to research conducted at The Icahn School of Medicine at Mount Sinai and published in the journal Biological Psychiatry.
UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by Dr. David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor's nutrients and energy supply.
As neurodegenerative disorders such as Parkinson's and Alzheimer's disease progress, misfolded proteins clump together in neurons, recruiting normal proteins in the cell to also misfold and aggregate.
New data on patient treatment satisfaction from the LEAD(TM) 6 trial presented on the 22nd October at the 20th World Diabetes Congress (International Diabetes Federation) shows that patients have higher overall treatment satisfaction with liraglutide than they do with exenatide.
The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.
› Verified 3 days ago